Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.
- DOI
- 10.1093/rheumatology/keag489
- Published
- 2026 Sep 1
- Container
- Rheumatology (Oxford, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keag489,
title = {Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.},
author = {Wu J and Wang J and Bai X and Liu Y and Ao Y and Liu J and Yang H and Zheng W},
year = {2026},
journal = {Rheumatology (Oxford, England)},
doi = {10.1093/rheumatology/keag489},
url = {https://doi.org/10.1093/rheumatology/keag489}
}RIS
TY - JOUR TI - Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study. AU - Wu J AU - Wang J AU - Bai X AU - Liu Y AU - Ao Y AU - Liu J AU - Yang H AU - Zheng W PY - 2026 JO - Rheumatology (Oxford, England) DO - 10.1093/rheumatology/keag489 UR - https://doi.org/10.1093/rheumatology/keag489 ER -
APA
J, W., J, W., X, B., Y, L., Y, A., J, L., H, Y., & W, Z. (2026). Efficacy and safety of upadacitinib in anti-TNF-refractory intestinal Behçet's disease: a single-center retrospective study.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag489
Source records
- pubmed · retrieved 2026-09-26T04:07:00.460Z